Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages

Infect Immun. 1993 Sep;61(9):4008-12. doi: 10.1128/iai.61.9.4008-4012.1993.

Abstract

Recently, it has been shown that interleukin-7 (IL-7) is able to induce secretion of cytokines and tumoricidal activity by human monocytes. This study shows that treatment of murine macrophages infected with Leishmania major with IL-7 without any other stimulus reduced the percentage of infected cells, as well as the parasite burden per cell, in a dose-dependent manner to a limited degree (45% reduction of the number of amastigotes per 100 macrophages). Simultaneous treatment of macrophages with gamma interferon and IL-7 led to nearly complete (> 99%) elimination of amastigotes. Addition of anti-tumor necrosis factor alpha or N omega-monomethyl-L-arginine acetate reversed the leishmanicidal effects of IL-7, and production of nitric oxide was induced in the presence of IL-7.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Female
  • Interferon-gamma / pharmacology
  • Interleukin-7 / pharmacology*
  • Leishmania tropica / immunology*
  • Macrophages / drug effects
  • Macrophages / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Nitric Oxide / metabolism
  • Phagocytosis / drug effects*
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Interleukin-7
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Interferon-gamma